KGK | Jotup

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs Second R&D Partnership Agreement with KGK Science for Development of GLP1 Supplement for Pets

Retrieved on:

목요일, 11월 16, 2023

Pet, Better Choice Parking, Cat, NYSE, KGK, Overweight, Consultant, Obesity, Animal, GLP1, Dog, APH, MOU

TAMPA, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced its research partner, Aimia Pet HealthCo.

Key Points:

TAMPA, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced its research partner, Aimia Pet HealthCo.
Inc. (APH), has signed a memorandum of understanding (MOU) with KGK Science Inc. (KGK) for the development of a GLP1 supplement for pets.
The MOU sets out the basis for KGK to commence research and development of a GLP1 supplement for use in companion animals.
KGK is a leading Canadian researcher organization that provides high-quality clinical research trials and expert regulatory support to several industries.

KYOCERA AVX Adds Safety-Certified Capacitors to its Extensive MLCC Product Portfolio

Retrieved on:

목요일, 11월 16, 2023

KGH, MLCC, EMI, KGK, Employment, Lightning, IEC, Copper, AC, UL, KYOCERA, Modem, Digi-Key, EN, Noise, Medical device, Electronics, Transformer, Mouser

FOUNTAIN INN, S.C., Nov. 16, 2023 /PRNewswire/ -- KYOCERA AVX, a leading global manufacturer of advanced electronic components engineered to accelerate technological innovation and build a better future, has expanded its extensive portfolio of commercial surface-mount MLCCs with the release of its first safety-certified MLCCs, the new Class X1/Y2 KGK Series and Class X2 KGH Series.

Key Points:

KYOCERA AVX released its first safety-certified MLCCs, which deliver high reliability, stability, and capacitance.
Class-X and Class-Y safety-certified capacitors are designed to protect against surges and transients and provide EMI filtering AC line filtering applications.
"The new KGK and KGH Series safety-certified capacitors complement our current commercial MLCC product portfolio and, thanks to their broad slate of certifications, allow us to provide customers all around the world with a complete package of parts for any application that requires a safety capacitor," said Zack Kozawa, Product Manager, KYOCERA AVX.
For more information about KYOCERA AVX's new KGK Series Class X1/Y2 and KGH Series Class X2 safety-certified capacitors, please visit https://www.kyocera-avx.com/products/ceramic-capacitors/surface-mount/sa... .

Arras Drilling Expands Resource Potential 1km to the South and Intercepts 500 Metres of Continuous Cu-Au-Ag Mineralization at Its Beskauga Licence in Kazakhstan

Retrieved on:

화요일, 9월 19, 2023

A 1 km drill step out from main deposit shows continued mineralization: Holes Bg23025 & Bg23026 were drilled 1 kilometer outside of the main mineral resource at Beskauga and returned 500m+ zones of continuous mineralization.

Key Points:

A 1 km drill step out from main deposit shows continued mineralization: Holes Bg23025 & Bg23026 were drilled 1 kilometer outside of the main mineral resource at Beskauga and returned 500m+ zones of continuous mineralization.
Including: 69.0 m grading 0.45 % CuEq - (0.39 g/t Au, 0.12% Cu, 0.70 g/t Ag) starting at 420.0 m depth down-hole.
Tim Barry, CEO, commented, “It is very pleasing to see long continuous zones of mineralization drilled well outside the existing resource at Beskauga.
It is also particularly pleasing to see zones of high-grade mineralization grading up 1.16% CuEq over 11 meters and 0.77% CuEq over 21 meters within these longer intercepts.

Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference

Retrieved on:

월요일, 6월 19, 2023

Andrew Charrette, Director Regulatory Affairs, KGK Science Inc., will participate on the “Decomposing Regulatory Risk: How to Develop and Market Compliant and Impactful Myco Products” panel at 2:30pm MDT on June 20th.

Key Points:

Andrew Charrette, Director Regulatory Affairs, KGK Science Inc., will participate on the “Decomposing Regulatory Risk: How to Develop and Market Compliant and Impactful Myco Products” panel at 2:30pm MDT on June 20th.
Psychedelic Science 2023 is the premier opportunity to reach a passionate audience over five days in Denver at the largest psychedelic community gathering in history.
Najla Guthrie, CEO of KGK & Wellbeing will participate on two panels:
Elephant in the Room?
For more information about the conference, or to schedule a one-on-one meeting with Wellbeing management team, please send an email to Natalie Dolphin at [email protected] .

Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group

Retrieved on:

금요일, 6월 16, 2023

Biotechnology, Health, Mental Health, Agreement, Shareholder, Therapy, Asset purchase agreement, Meeting, FRA, MEDI, KGK, Sales management, Acquisition, Transaction, OTC, SQ2, NEO, Security (finance)

In consideration for the acquisition of KGK, the Purchaser has agreed to pay $2,000,000 (the “Purchase Price”), from which they advanced a non-refundable deposit of $200,000 upon signing of the Purchase Agreement.

Key Points:

In consideration for the acquisition of KGK, the Purchaser has agreed to pay $2,000,000 (the “Purchase Price”), from which they advanced a non-refundable deposit of $200,000 upon signing of the Purchase Agreement.
Further deposits can be advanced at the discretion of the Purchaser, subject to the approval of the Company, prior to completion of the Transaction.
The Company and KGK are at arms-length from the Purchaser, and no finders’ fees or commissions are payable by the Company in connection with the entering into of the Purchase Agreement.
During the period between the signing of the Agreement and the closing of the Transaction, Wellbeing will continue to operate the business in accordance with customary interim operating covenants.

Arras Minerals Intercepts 603.7m @ 0.40% CuEq, Including 317.6m @ 0.55% CuEq on the Beskauga Licence, Northeastern Kazakhstan

Retrieved on:

목요일, 5월 25, 2023

Including: 65.0 m grading 0.44g/t AuEq (0.41 g/t Au, 0.02% Cu, 0.2 g/t Ag) starting at 105.0 m depth down-hole.

Key Points:

Including: 65.0 m grading 0.44g/t AuEq (0.41 g/t Au, 0.02% Cu, 0.2 g/t Ag) starting at 105.0 m depth down-hole.
Including: 34.0 m grading 0.30g/t AuEq (0.28 g/t Au, 0.01% Cu, 0.13 g/t Ag) starting at 243.0 m depth down-hole.
Mr. Tim Barry, CEO commented, “Drilling at Beskauga continues to deliver near-surface, broad intervals of significant copper-gold mineralization.
Drill hole also targeted deeper extension of mineralization based on the defined steep SW plunge of Beskauga Main Cu-Au mineralization.

Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference

Retrieved on:

목요일, 5월 25, 2023

Mental Health, Health, Fitness & Nutrition, Research, Science, Pharmaceutical, Biotechnology, MEDI, KGK, Therapy, SQ2, NEO, FRA, OTC

Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that its subsidiary KGK Science Inc. (“KGK” or the “Subsidiary”) will participate at the upcoming Nutrition Industry Association (“NIA”) Spring Forum to take place on May 29 to June 1, 2023 in California.

Key Points:

Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that its subsidiary KGK Science Inc. (“KGK” or the “Subsidiary”) will participate at the upcoming Nutrition Industry Association (“NIA”) Spring Forum to take place on May 29 to June 1, 2023 in California.
Najla Guthrie will participate on the “From functional food to prescription medication, mushrooms are the center of the conversation” panel at 11:00 AM PST on Tuesday May 30th.
Industry professionals will gather once again for the Nutrition Industry Association’s annual Spring meeting.
For more information about the conference, or to schedule a one-on-one meeting with the KGK management team, please send an email to Natalie Dolphin at [email protected] .

Arras Minerals Completes Analytical Review of 2022 Regional Exploration Licence Field Program

Retrieved on:

수요일, 5월 10, 2023

ARK, Geology, Geo, KGK, Gold, Soil, National instrument, National Instrument 43-101, Quality of analytical results, News, Stepno, Rare-earth element, Uranium mining, Eleme people

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- Arras Minerals Corp. (TSX-V: ARK) (“Arras” or “the Company”) is pleased to provide a summary of the analysis completed from the Company’s 2022 regional exploration field program.

Key Points:

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- Arras Minerals Corp. (TSX-V: ARK) (“Arras” or “the Company”) is pleased to provide a summary of the analysis completed from the Company’s 2022 regional exploration field program.
Highlights of the Analytical Results from 2022 Exploration Field Program:
Over 16,000 soil samples were collected during the Arras summer field program and analyzed using a portable X-ray fluorescent (pXRF) analyzer.
The pXRF results confirmed the presence of widespread mineralization in the targeted areas that were identified through Arras’ 2022 work program and historic Soviet-era geological reports.
Tim Barry, CEO of Arras, commenting on the results from the 2022 regional field programs, stated, “We are pleased to announce the summary results of our extensive 2022 soil sample program.

Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial

Retrieved on:

화요일, 4월 18, 2023

The 28-day study will test the safety and efficacy of Nova Mentis’ proprietary psilocybin drug (NM-1001) for the treatment of FXS and is one of the first Health Canada approved studies allowing participants to take home psilocybin for dosing every other day.

Key Points:

The 28-day study will test the safety and efficacy of Nova Mentis’ proprietary psilocybin drug (NM-1001) for the treatment of FXS and is one of the first Health Canada approved studies allowing participants to take home psilocybin for dosing every other day.
Nova Mentis and KGK have partnered to conduct the Phase IIA clinical trial, which is being carried out at the KGK facility in London, Ontario, Canada.
This 10-person, open-label study will assess repetitive, oral microdose psilocybin therapy for FXS.
“KGK Science is eager to begin testing the efficacy of microdosing psilocybin in this cutting-edge clinical trial.

Arras Minerals Intercepts 778.2m @ 0.40% CuEq, Including 322.4m @ 0.51% CuEq on the Beskauga Licence, Northeastern Kazakhstan

Retrieved on:

수요일, 4월 5, 2023

Including: 95.2 m grading 0.61 % CuEq (0.47 g/t Au, 0.20% Cu, 1.27 g/t Ag) starting at 268.0m depth down-hole.

Key Points:

Including: 95.2 m grading 0.61 % CuEq (0.47 g/t Au, 0.20% Cu, 1.27 g/t Ag) starting at 268.0m depth down-hole.
Including: 322.4 m grading 0.51 % CuEq (0.40 g/t Au, 0.16% Cu, 1.15 g/t Ag) from 446.0m depth down-hole.
Including: 8.0 m grading 1.14g/t AuEq (0.56 g/t Au, 0.45% Cu, 1.12 g/t Ag) starting at 369.0 m depth down-hole.
Including: 12.0 m grading 1.65g/t AuEq (1.27 g/t Au, 0.21% Cu, 3.28 g/t Ag and 204.63 ppm Mo) starting at 376.0m depth down-hole.